CASI PHARMACEUTICALS, INC. Deferred Tax Liabilities, Net
CASI PHARMACEUTICALS, INC. had Deferred Tax Liabilities, Net of $4.40 million as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Net
us-gaap:DeferredTaxLiabilities · last filed 2022-03-28
- 2021-12-31: Deferred Tax Liabilities, Net $4.40M.
- 2020-12-31: Deferred Tax Liabilities, Net $3.62M.
| Period end | Deferred Tax Liabilities, Net |
|---|---|
| 2021-12-31 | $4.40M 10-K · filed 2022-03-28 |
| 2020-12-31 | $3.62M 10-K · filed 2022-03-28 |